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TO THE EDITOR
Melanocortin receptor 1 (MC1R), a
G-protein-coupled receptor on mela-
nocytes, plays an important role in
melanogenesis. Binding of a-melano-
cyte-stimulating hormone induces bio-
synthesis of eumelanin (black melanin).
MC1R (OMIM 155555) is highly
polymorphic, and some variants are
related to melanogenic phenotypes. In
Caucasians, specific variants such as
Arg142His, Arg151Cys, Arg160Trp and
Asp294His are strongly associated with
freckles and solar lentigines (Flanagan
et al., 2000; Bastiaens et al., 2001; Box
et al., 2001). All these variants are
known to cause impaired receptor
function in MC1R (Frandberg et al.,
1998; Schioth et al., 1999; Scott et al.,
2002) and/or reduced cell surface
expression of the receptor (Beaumont
et al., 2005; Garcia-Borron et al.,
2005). Decreased apparent sensitivity
to melanocyte-stimulating hormone per
melanocyte thus appears to represent
an important factor in the development
of freckles and solar lentigines.
We recently observed clear associa-
tions of Val92Met and Arg163Gln with
freckles and solar lentigines in Japanese
subjects (Motokawa et al., 2007). Since
the Val92Met variant is known to cause
impaired receptor function (Xu et al.,
1996; Ringholm et al., 2004), this
variant appears to be consistent with
the standard hypothesis. However,
MC1R with the Arg163Gln variant
shows almost identical response to
a-melanocyte-stimulating hormone as
wild-type MC1R receptor (Ringholm
et al., 2004) and no change in expres-
sion on the cell surface (Beaumont
et al., 2005). Since Arg163Gln does
not seem to directly affect sensitivity of
melanocytes to agonist, we created
an alternative hypothesis for the
Arg163Gln variant: the 163Gln allele
may also be associated with other
polymorphic sites in the same locus,
influencing apparent sensitivity of the
melanocyte to melanocyte-stimulating
hormone. Considering these condi-
tions, polymorphism in the promoter
Table 1. Variants in the promoter region of MC1R in Japanese individuals
Nucleotide mutation Number of alleles Allele frequencies
636C4G1 1/494 0.998/0.002
616C4T 1/494 0.998/0.002
490C4T 392/494 0.206/0.794
465C4G1 1/494 0.998/0.002
445G4A 388/494 0.215/0.785
409G4C1 1/494 0.998/0.002
356A4G1 4/494 0.992/0.008
226A4T 388/494 0.215/0.785
488G4A (Arg163Gln) 387/502 0.229/0.771
Genomic DNA was isolated from 10 eyebrow hairs collected from each of 251 randomly selected
Japanese subjects, according to a previously reported method (Motokawa et al., 2006). DNA was
amplified by PCR to generate 882 bp (including 136 bp of the coding region and 746 bp of the
promoter region) using primers F (ttgacagctgagttgctgct) and R (aggaagagcccgtcagagat). PCR conditions
were set as follows: 5min activation at 941C, followed by 35 cycles at 981C for 5 s, 671C for 1min and
721C for 20min for extension. Sequence analysis (1 to 718bp) was performed using an ABI
BigDye Terminator Cycle Sequencing Kit (version 3.1, 4337455; Applied Biosystems, Tokyo, Japan)
using primers A (acccctgtcctccctgag), B (caggaaggcaggagacagag), C (tcagagatggacacctccag), and D
(gacacctcctggcatctacc). The coding region of the G488A allele corresponding to amino-acid residue
163 was sequenced according to previously reported methods (Motokawa et al., 2006). This study
was conducted in compliance with the Declaration of Helsinki Principles. The protocol was approved
by the POLA Ethical Committee, and written informed consent was obtained from all participants.
The G488A allele was detected in all individuals, and the promoter region was completely read in
247 of 251 individuals.
1Previously not identified variants.
Abbreviation: MC1R, melanocortin-1 receptor
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region of MC1R seems central to sol-
ving the mystery associated with
Arg163Gln. This study therefore exam-
ined whether there exist variants linked
to Arg163Gln in the promoter region of
MC1R and any variants linked to
Arg163Gln would then undergo an
association study between variants and
pigmented lesions (freckles and solar
lentigines) to assess our hypothesis.
Among 247 Japanese individuals,
we found eight variants in the promoter
region (from 1 to 746bp) of MC1R,
including four previously unknown
alleles (Table 1). Of these, three variants
(490C4T, 445G4A, 226A4T)
were highly polymorphic (41%). We
then performed haplotype analysis
using data for the three polymorphic
alleles and G488A allele (corresponding
to Arg163Gln). A total of five haplo-
types were identified for Japanese sub-
jects (Figure 1a). The most common
–490
Type p-JA
T A T
C
X X X
G A
Type p-JB
Intermediates
–445 –226
Number of promoter haplotypes
(frequency)
388/494 (78.5%)
101/494 (20.4%)
5/494 (1.0%)
Human
consensus
–490
C
T T
G G
Number of haplotypes
(frequency)
382/494 (77.3%)
101/494 (20.4%)
6/494 (1.2%)
4/494 (0.8%)
1/494 (0.2%)
A
C G GA
A A
T
T
C G T A
G A G
TA G
–445 –226 488
Type 1
Type 2
Type 3
Type 4
Type 5
Figure 1. Haplotype pattern of three alleles in the promoter region and one allele in the coding region. In 247 of 251 subjects, the promoter region
was completely read. Total number of haplotypes used to calculate frequencies was 494. Haplotype analysis was performed using SNPAlyze (Dynacom,
Kanagawa, Japan). (a) Results of haplotype analysis using data for three polymorphic variants in the promoter (490C4T, 445G4A, 226A4T) and
one variant in the coding region (488G4A) corresponding to the Arg163Gln allele. Five haplotype patterns were identified. Frequency of the human
consensus haplotype (type 2) was only 20.4%. (b) Haplotype pattern of three alleles in the promoter region. The p-JA was defined as the most common
haplotype, with p-JB as the second-most common type. Almost all Japanese (98.9%) display either type.
Table 2. Association between promoter haplotypes and pigment disorders
Number of
subjects
Haplotype (frequency)
Odds ratio for p-JB
haplotype (95% CI)p-JA p-JB P-value
Freckles
Present 19 24 (0.63) 14 (0.37) 0.017* 2.42 (1.18–4.83)
Absent 219 353 (0.81) 85 (0.10)
Solar lentigines
Severe 112 168 (0.75) 56 (0.25) 0.019* 1.74 (1.10–2.80)
Non-severe 112 188 (0.84) 36 (0.16)
CI, confidence interval.
The method to diagnose pigmentation disorders (freckles and solar lentigines) for each individual was
mentioned in a previous report (Motokawa et al., 2007). In brief, an experienced dermatologist
diagnosed the face based on criteria described in other reports (Hodgson, 1963; Bastiaens et al.,
2001). For freckles, individuals were placed into present and absent groups. For solar lentigines,
individuals were classified based on severity of the disorder, as almost all individuals displayed solar
lentigines to some degree. Each subject was given a score by three researchers based on the standard
photograph that was the closest to the face of the individual. Subjects were then grouped into severe
and non-severe groups based on the median score of all participants. Total number of individuals for
whom phenotype data were collected was 238 (freckles) and 224 (solar lentigines). Statistical
analyses were performed using JMP for Windows software (version 5.0.1J; SAS Institute, Cary, NC).
*Po0.05.
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haplotype (77.3%) was type 1 (490T,
445A, 226T, 488A) and the second-
most common (20.4%) was type 2
(490C, 445G, 226A, 488G). These
two types accounted for nearly all
Japanese haplotypes (97.7%). Among
haplotypes displaying the 488A
(163Gln) allele, almost all (99.7%;
382/383) displayed the sequence com-
bination of [490T, 445A, 226T] in
the promoter region. Conversely,
among haplotypes with the 488G al-
lele, most (91.0%; 101/111) displayed
the sequence combination of [490C,
445G, 226A]. These results clearly
show that the Arg163Gln allele is
associated with the combination of
three alleles in the promoter region.
Next, we studied whether combinations
in the promoter region are associated
with pigmented lesions. We defined the
most common combination as p-JA and
the second-most common type as p-JB
(Figure 1b). We then performed an
association study between p-JA, p-JB,
and pigmented lesions (freckles and
solar lentigines). Positive associations
were found between promoter haplo-
type and freckles (P¼0.017) and solar
lentigines (P¼ 0.019) using the w2 test
(Table 2). Using logistic regression
modeling, positive associations were
observed between number of p-JB and
development of both freckles (P¼ 0.021)
and solar lentigines (P¼0.021; Table 3).
In this model, compared to subjects
without the p-JB haplotype, subjects
who were homozygous for the p-JB
haplotype displayed a much greater
chance of developing freckles (odds
ratio, 5.26; 95% confidence interval,
1.29–20.83; Table 3a) and severe solar
lentigines (odds ratio, 2.93; 95% con-
fidence interval, 1.17–7.62; Table 3b).
This study sequenced the promoter
region (from 1 to 746bp) of MC1R
in Japanese individuals, revealing eight
variants that included three highly
polymorphic variants (490C4T,
445G4A, 226A4T). Using haplo-
type analysis, we found that the combi-
nation of three variants was related to
the G488A (Arg163Gln) allele. We then
performed an association study with
pigmented disorders, revealing clear
associations between the sequence
combination of [490C, 445G,
226A] and both freckles and solar
lentigines. To our knowledge, relation-
ship between polymorphisms in the
promoter region and phenotype is
previously unreported. Since the
G488A (Arg163Gln) allele apparently
does not influence MC1R function
(Ringholm et al., 2004) or expression
on the cell surface (Beaumont et al.,
2005), our results suggest that the
presence of any or all of the
three variants in the promoter region
affects the function or expression of
MC1R, making melanocytes less sensi-
tive to melanocyte-stimulating hor-
mone. Moro et al. (1999) performed
a promoter assay of MC1R using
human melanoma, and found that a
deletion from 517 to 447 (location
of the SP-1 site) completely abolishes
promoter activity. The combination of
those data and our data implies that the
490C4T variant in the promoter
region of MC1R might affect promoter
activity leading to decreased MC1R
expression.
In the haplotype analysis, we also
found that only two haplotypes (types 1
and 2) account for almost all Japanese
haplotypes (97.7%). Type 2 represents
the human consensus sequence, while
type 1 shows substitutions for all four
alleles. Interestingly, the mixture of
these two haplotypes was rare (2.2%).
These results seem unusual, in that,
if the common type (type 1) evolved
from the human consensus (type 2) in
Japan, numerous intermediates should
be expected. We thus propose two
hypotheses: (1) individuals displaying
intermediate sequences might be
disadvantaged under certain circum-
stances and (2) two ancestral groups, each
displaying only type 1 or only type 2,
might have migrated to Japan separately.
Further study is required to determine
which, if any, of these hypotheses is more
plausible, such as promoter assay of the
mixed sequence to assess the possibility of
the first hypothesis, and haplotype analysis
using DNA collected from other Asian
populations to examine the second
hypothesis.
Table 3. Association between total number of p-JB haplotypes and
development of freckles (a) or solar lentigines (b)
Number of p-JB
haplotypes Freckles
Number of
subjects
Odds ratio
(95% CI) P-value
(a)
0 (63.9%) Present 8 1 0.021*
Absent 144
1 (30.7%) Present 8 2.29 (1.14–4.56)
Absent 65
2 (5.5%) Present 3 5.26 (1.29–20.83)
Absent 10
(b)
Number of p-JB
haplotypes Solar lentigines
Number of
subjects
Odds ratio
(95% CI) P-value
0 (63.9%) Severe 65 1 0.021*
Non-severe 78
1 (30.7%) Severe 38 1.71 (1.08–2.76)
Non-severe 32
2 (5.5%) Severe 9 2.93 (1.17–7.62)
Non-severe 2
CI, confidence interval.
Using logistic regression modeling, positive associations were observed between number of p-JB and
development of both freckles (P=0.021) and solar lentigines (P=0.021). Positive trends across the
number of variants were confirmed using the Cochran–Armitage trend test (freckles, P=0.014; solar
lentigines, P=0.022).
*Po0.05.
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TO THE EDITOR
Eczema (Johansson et al., 2004) is a
common inflammatory skin disorder
associated with epidermal barrier
dysfunction (Jakasa et al., 2007). The
finding that null mutations within
the filaggrin gene (FLG) are strong
predisposing factors for atopic eczema
has been demonstrated and replicated
in multiple independent case–control
and association studies from different
European populations, as recently
reviewed by Irvine (2007). FLG is
located within the epidermal differen-
tiation complex on chromosome 1q21,
a cluster of genes involved in the
terminal differentiation of keratinocytes
(Mischke et al., 1996). FLG is expressed
in the granular layer of the stratum
corneum during terminal epidermal
differentiation. It aggregates the keratin
cytoskeleton to facilitate the collapse
and flattening of keratinocytes to pro-
duce squames (Manabe et al., 1991);
filaggrin may also contribute to epider-
mal barrier function following its degra-
dation to release hygroscopic amino
acids (Rawlings and Harding, 2004).
Detailed study of the structure and
function of the FLG gene has revealed
five prevalent null mutations within
the European population, as well as
multiple low-frequency null mutations,
some of which may be family specific
(Sandilands et al., 2007b). These
mutations have been found in 47% of
one eczema case series and together
they make a significant contribution to
the genetic susceptibility to atopic
eczema (Sandilands et al., 2007a).
Following on from a previous report
where the two most common FLG
mutations (R501X and 2282del4) were
strongly associated with early-onset
eczema persisting into adulthood
(Barker et al., 2007), we have extended
that case–control study to investigate
the significance of all five of the
recently described and most prevalent
FLG mutations. We studied a total of
186 adult eczema patients from London
and Newcastle-upon-Tyne, UK, whose
eczema had begun in early child-
hood. Their phenotypic characteristics
are as reported previously (Barker
et al., 2007). We similarly screened an
unselected population birth cohort
of 1,035 individuals from the northwest
of England, of unknown phenotype,
for use as a control population.
The study was carried out in accor-
dance with the Declaration of HelsinkiAbbreviation: FLG, filaggrin gene
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